Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005599
What this trial is testing

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00030524
What this trial is testing

ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
The University of Texas Health Science Center at San Antonio
Testing effectiveness (Phase 2)WithdrawnNCT02736123
What this trial is testing

Neoadjuvant Combination Biotherapy With Ipilimumab and Nivolumab or Nivolumab Alone

Who this might be right for
Melanoma
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT00030537
What this trial is testing

Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00589056
What this trial is testing

Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Lung Cancer
Abramson Cancer Center at Penn Medicine 55
Testing effectiveness (Phase 2)UnknownNCT00690872
What this trial is testing

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 35
Testing effectiveness (Phase 2)UnknownNCT01118039
What this trial is testing

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Hospital del Mar 41
Large-scale testing (Phase 3)Ended earlyNCT00925548
What this trial is testing

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

Who this might be right for
Breast Cancer
EMD Serono 16
Not applicableEnded earlyNCT00660348
What this trial is testing

Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Who this might be right for
PainPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Testing effectiveness (Phase 2)UnknownNCT03854838
What this trial is testing

IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsNasopharyngeal Diseases+1 more
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Study completedNCT00792025
What this trial is testing

Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Institut Curie 80
Testing effectiveness (Phase 2)Study completedNCT00066846
What this trial is testing

Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT02523378
What this trial is testing

Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-Completion

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 138
Not applicableUnknownNCT06114420
What this trial is testing

Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer

Who this might be right for
Locally Recurrent Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 500
Testing effectiveness (Phase 2)Study completedNCT00072176
What this trial is testing

Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous Cell CarcinomaEndometrial Clear Cell Carcinoma+7 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT01175980
What this trial is testing

Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma

Who this might be right for
Recurrent Oral Cavity Adenoid Cystic CarcinomaRecurrent Salivary Gland CarcinomaSalivary Gland Adenoid Cystic Carcinoma+9 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00055861
What this trial is testing

Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT03813394
What this trial is testing

Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC

Who this might be right for
Locally Recurrent CancerMetastatic Nasopharyngeal Cancer
National University Hospital, Singapore 48
Early research (Phase 1)Study completedNCT05152212
What this trial is testing

Study of LVGN7409 (CD40 Agonist Antibody) in Locally Advanced, Metastatic or Recurrent/Refractory Malignancy

Who this might be right for
Cancer
Lyvgen Biopharma Holdings Limited 33
Large-scale testing (Phase 3)Looking for participantsNCT06263231
What this trial is testing

Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

Who this might be right for
Sarcoma,Soft Tissue
Intensity Therapeutics, Inc. 333
Next Page